Crossmark

A meta-analysis of animal studies evaluating the effect of hydrogen sulfide on ischemic stroke: is the preclinical evidence sufficient to move forward?

Crossref DOI link: https://doi.org/10.1007/s00210-024-03291-5

Published Online: 2024-07-17

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Emre Aydıngöz, Selda https://orcid.org/0000-0001-7823-7620
Teimoori, Ariyan https://orcid.org/0000-0002-3299-9491
Orhan, Halit Güner https://orcid.org/0000-0003-2489-5358
Demirtaş, Elif https://orcid.org/0000-0002-6024-8038
Zeynalova, Nargız https://orcid.org/0000-0002-2849-5581
Funding

Funding for this research was provided by:

Baskent University
License Information

Text and Data Mining valid from 2024-07-17

Version of Record valid from 2024-07-17
More Information

Article History

Received: 5 June 2024

Accepted: 8 July 2024

First Online: 17 July 2024

Declarations

:

: The study was not subject to ethics committee approval because it did not involve any experimental or clinical intervention.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below